Search

Your search keyword '"Saarela, Janna"' showing total 468 results

Search Constraints

Start Over You searched for: Author "Saarela, Janna" Remove constraint Author: "Saarela, Janna"
468 results on '"Saarela, Janna"'

Search Results

1. Identification of DHX40 as a candidate susceptibility gene for colorectal and hematological neoplasia

3. Truncating NFKB1 variants cause combined NLRP3 inflammasome activation and type I interferon signaling and predispose to necrotizing fasciitis

6. Homozygosity of a Founder Variant c.1508dupC in DOK7 Causes Congenital Myasthenia With Variable Severity

8. Multiple sclerosis genomic map implicates peripheral immune cells and microglia in susceptibility

9. 49 Early-Onset Common Variable Immunodeficiency in a Patient with Heterozygous Variants in Interferon Response-Associated Genes TRAF3 and IRF4

10. Impact of Genetic Susceptibility on Multiple Sclerosis Immune Methylome (S17.006)

12. Author Correction: A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis

13. A systems biology approach uncovers cell-specific gene regulatory effects of genetic associations in multiple sclerosis

14. Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients

15. Meeting summary of The NYO3 5th NO-Age/AD meeting and the 1st Norway-UK joint meeting on ageing and dementia: recent progress on the mechanisms and interventional strategies

16. Correction to: Hematopoietic Cell Transplantation Cures Adenosine Deaminase 2 Deficiency: Report on 30 Patients

17. Heterozygous TLR3 Mutation in Patients with Hantavirus Encephalitis

18. Class II HLA interactions modulate genetic risk for multiple sclerosis.

20. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.

21. Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.

22. A Family With A20 Haploinsufficiency Presenting With Novel Clinical Manifestations and Challenges for Treatment

23. Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis.

24. A Maturity Level Model (MLM) for the self-assessment of genomic medicine practices in healthcare systems

26. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2

28. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis.

29. Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

30. Supplementary Data from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

31. Supplementary Tables from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

32. Data from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

33. Supplementary Figures from Implementing a Functional Precision Medicine Tumor Board for Acute Myeloid Leukemia

34. Data from A Single-Nucleotide Substitution Mutator Phenotype Revealed by Exome Sequencing of Human Colon Adenomas

35. Supplementary Figures 1-5, Tables 1-5 from A Single-Nucleotide Substitution Mutator Phenotype Revealed by Exome Sequencing of Human Colon Adenomas

36. Supplementary Figure Legends 1-5 from A Single-Nucleotide Substitution Mutator Phenotype Revealed by Exome Sequencing of Human Colon Adenomas

37. Do monogenic inborn errors of immunity cause susceptibility to severe COVID-19?

38. Finding disease candidate genes by liquid association

39. Evaluation and Management of Deficiency of Adenosine Deaminase 2: An International Consensus Statement

40. Long-term follow up of families with pathogenic NFKB1 variants reveals incomplete penetrance and frequent inflammatory sequelae

43. Locus for severity implicates CNS resilience in progression of multiple sclerosis.

44. Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3

45. Damaging heterozygous mutations in NFKB1 lead to diverse immunologic phenotypes

47. A Family With A20 Haploinsufficiency Presenting With Novel Clinical Manifestations and Challenges for Treatment

48. The Role of the CD58 Locus in Multiple Sclerosis

50. Loss-of-function mutation in IKZF2 leads to immunodeficiency with dysregulated germinal center reactions and reduction of MAIT cells

Catalog

Books, media, physical & digital resources